Recursion Pharmaceuticals

RXRX · NASDAQ

$3.66+$0.05 (+1.39%)TodayMarket closed · Oct 20, 7:57 PM ET

Prev close $3.61

Latest news

NewsOct 16, 1:19 AM ETMohd Haider
Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know
Press releaseOct 15, 8:45 AM ETGlobe Newswire
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
Press releaseOct 15, 8:30 AM ETGlobe Newswire
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
Press releaseOct 15, 8:22 AM ETGlobe Newswire
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
NewsOct 6, 11:46 AM ETChandrima Sanyal
Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
NewsSep 25, 2:00 PM ETErica Kollmann
Squeeze Watch: 10 Stocks With Over 33% Short Interest
Press releaseSep 21, 9:14 AM ETBusiness Wire
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
NewsSep 17, 9:22 AM ET
Recursion Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
Press releaseSep 3, 2:10 PM ETGlobe Newswire
The Market Just Told You Which Layer Of AI Biology It Is Paying For
NewsAug 20, 5:59 AM ETMohd Haider
Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
NewsAug 13, 8:00 AM ETAvi Kapoor
Jim Cramer: These Utilities Stocks Are 'Oversold,' Fastly 'Back From The Abyss'
Press releaseAug 5, 6:30 AM ETGlobe Newswire
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Press releaseJul 29, 8:30 AM ETGlobe Newswire
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
Press releaseJul 24, 9:10 AM ETPRNewswire
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
Press releaseJul 1, 9:00 AM ETPRNewswire
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
NewsJul 1, 7:50 AM ETSurbhi Jain
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
Press releaseJun 30, 9:00 AM ETPRNewswire
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs
Press releaseJun 16, 8:45 AM ETPRNewswire
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
Press releaseMay 11, 8:30 AM ETGlobe Newswire
The Future of Intoxication Detection May Be in Your Voice
NewsMay 7, 1:04 PM ETPriya Nigam
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
Press releaseMay 6, 6:30 AM ETGlobe Newswire
Recursion Reports First Quarter Financial Results and Provides Business Update
Press releaseApr 29, 7:59 AM ETGlobe Newswire
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6
Press releaseMar 16, 10:00 AM ETGlobe Newswire
Nvidia's Bet on Digital Biology and Stocks That Could Ride the Wave
Press releaseFeb 25, 9:38 AM ETGlobe Newswire
AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone
Press releaseFeb 25, 6:30 AM ETGlobe Newswire
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
NewsFeb 24, 3:52 PM ETErica Kollmann
ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025
NewsFeb 24, 2:02 PM ET
Recursion Pharmaceuticals's Earnings Outlook
NewsFeb 18, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseFeb 10, 9:29 AM ETGlobe Newswire
AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
Press releaseJan 29, 9:25 AM ETPRNewswire
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
NewsDec 26, 1:28 PM ET
3 Small AI Plays to Buy for 2026
NewsDec 17, 9:28 PM ETShivdeep Dhaliwal
Cathie Wood's Big Crypto Bet: Ark Scoops Up Bitmine, Coinbase As Bitcoin, Ethereum Continue To Bleed, Dumps This Amazon Rival
NewsDec 17, 1:06 PM ETEvette Mitkov
Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why
NewsDec 17, 10:07 AM ETAvi Kapoor
Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday
Press releaseDec 11, 10:17 AM ETPRNewswire
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Press releaseNov 18, 8:45 AM ETGlobe Newswire
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
NewsOct 15, 10:47 AM ETAvi Kapoor
Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday
NewsOct 8, 9:52 PM ETShivdeep Dhaliwal
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today
NewsOct 8, 2:51 PM ETVandana Singh
What's Going On With Recursion Pharmaceuticals Stock On Wednesday?
NewsOct 8, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today's Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know

Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration

Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock

Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone

Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

Squeeze Watch: 10 Stocks With Over 33% Short Interest

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model

Recursion Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

The Market Just Told You Which Layer Of AI Biology It Is Paying For

Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why

Jim Cramer: These Utilities Stocks Are 'Oversold,' Fastly 'Back From The Abyss'

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data

Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI

A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

The Future of Intoxication Detection May Be in Your Voice

Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back

Earnings Scheduled For May 6, 2026

Recursion Reports First Quarter Financial Results and Provides Business Update

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

Nvidia's Bet on Digital Biology and Stocks That Could Ride the Wave

AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025

Recursion Pharmaceuticals's Earnings Outlook

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation

AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift

3 Small AI Plays to Buy for 2026

Cathie Wood's Big Crypto Bet: Ark Scoops Up Bitmine, Coinbase As Bitcoin, Ethereum Continue To Bleed, Dumps This Amazon Rival

Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why

Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday

Platform Technologies Drive $211B Surge in Precision Cancer Treatment

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday

Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today

What's Going On With Recursion Pharmaceuticals Stock On Wednesday?

10 Health Care Stocks Whale Activity In Today's Session